This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Giant cell arteritis with polymyalgia rheumatica
GIANT_CELL_TEMP_ARTERITIS
polymyalgia rheumatica: Polymyalgia rheumatica is a common inflammatory condition that often affects people over the age of 50 years. Characteristic symptoms are shoulder and hip girdle pain and prolonged morning stiffness. Markers of inflammation are often elevated.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1253 |
4. Check minimum number of eventsNone |
1253 |
5. Include endpointsNone |
1253 |
6. Filter based on genotype QC (FinnGen only) |
1253 |
Control definitions (FinnGen only)
- Control exclude
- NECROVASC_FG
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M31
- Name in latin
- Arteritis gigantocellularis cum polymyalgia reumatica
Similar endpoints
↥List of similar endpoints to
Giant cell arteritis with polymyalgia rheumatica
based on the number of shared cases.
Similar with more cases:
- Temporal arteritis
- Giant cell arteritis
- Other necrotizing vasculopathies (FG)
- Other necrotizing vasculopathies
- Systemic connective tissue disorders
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1253 | 779 | 474 |
| Unadjusted period prevalence (%) | 0.24 | 0.27 | 0.21 |
| Median age at first event (years) | 69.88 | 69.52 | 70.47 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1110
- Matched controls
- 11102
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
4503599627370496.0
323.0
1108
*
PAW37
NOMESCO Finland
Biopsy of temporal artery
359.8
323.0
475
23
H02AB06
ATC
prednisolone; systemic
16.8
285.2
1006
4049
M35.3
ICD-10 Finland
Polymyalgia rheumatica
23.4
278.9
422
284
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
6.2
170.1
799
3243
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
9.0
145.2
343
524
M31.6
ICD-10 Finland
Other giant cell arteritis
165.2
139.0
144
10
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.9
126.6
368
749
M05BA04
ATC
alendronic acid; oral
6.4
118.5
365
792
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
8.8
99.0
228
315
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
14.3
93.7
165
134
I77.6
ICD-10 Finland
Arteritis, unspecified
143.1
87.4
92
7
A02BC02
ATC
pantoprazole; systemic
4.3
84.3
934
6147
R51.80
ICD-10 Finland
Headache
4.6
77.0
311
861
M35.1
ICD-10 Finland
Other overlap syndromes
42.7
66.8
83
21
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.7
64.6
203
419
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
55.6
672
3986
R50.9
ICD-10 Finland
Fever, unspecified
3.5
49.2
266
911
TPX00
NOMESCO Finland
Biopsy of artery or vein
90.9
47.3
52
6
H02AB07
ATC
prednisone; oral
3.2
44.4
277
1046
L88
ICPC
Rheumatoid/seropositive arthritis
6.4
41.2
113
192
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.3
38.7
227
811
L04AX01
ATC
azathioprine; systemic
6.1
37.0
105
186
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.8
35.4
276
1183
M31.3
ICD-10 Finland
Wegener granulomatosis
+∞
34.6
33
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.0
32.9
140
383
AA1AD
NOMESCO Finland
CT of head and brain
2.2
29.4
378
2083
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.8
29.2
210
847
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
299.4
28.9
29
*
N01
ICPC
Headache
3.6
28.4
139
427
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.6
27.4
83
159
G44.2
ICD-10 Finland
Tension-type headache
2.7
24.8
190
792
M05BA07
ATC
risedronic acid; oral
4.0
23.6
98
261
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
23.6
406
2480
J01DB01
ATC
cefalexin; oral
2.1
22.7
902
7464
H53.1
ICD-10 Finland
Subjective visual disturbances
3.4
22.5
117
376
N02BE01
ATC
paracetamol; systemic, rectal
2.4
21.7
994
8643
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.2
21.7
84
210
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.0
21.2
130
469
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
21.2
342
2019
M13.9
ICD-10 Finland
Arthritis, unspecified
3.1
20.8
118
404
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
22.9
20.4
29
13
H57.1
ICD-10 Finland
Ocular pain
5.2
20.3
64
129
ZX120
NOMESCO Finland
Intravenous
2.7
20.1
150
611
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
19.9
289
1626
M79.6
ICD-10 Finland
Pain in limb
1.8
18.8
438
2919
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
18.6
235
1241
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
18.2
457
3116
M35.5
ICD-10 Finland
Multifocal fibrosclerosis
23.2
17.8
25
11
A01
ICPC
Pain general/multiple sites
2.7
17.5
131
531
H04.10
ICD-10 Finland
Dry eye syndrome
2.5
17.4
151
667
M25.5
ICD-10 Finland
Pain in joint
1.9
17.3
321
1967
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
6.3
17.3
46
76
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.9
17.2
57
122
M05BX04
ATC
denosumab; parenteral
2.9
16.8
105
381
L04AA13
ATC
leflunomide; oral
4.7
16.7
57
126
S18
ICPC
Laceration/cut
1.7
16.0
518
3768
N03AX12
ATC
gabapentin; oral
2.1
15.9
210
1125
R51
ICD-10 Finland
Headache
3.6
15.8
73
214
P01BA02
ATC
hydroxychloroquine; oral
2.6
15.7
124
520
M79.1
ICD-10 Finland
Myalgia
2.2
15.7
166
806
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
+∞
15.7
15
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
15.3
542
4029
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
7.5
15.0
35
48
N02AX02
ATC
tramadol; systemic, rectal
1.7
14.9
501
3659
WX110
NOMESCO Finland
Local anesthesy
1.7
14.9
694
5545
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.3
14.7
74
233
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
14.6
145
682
R06.0
ICD-10 Finland
Dyspnoea
1.8
14.3
333
2174
R53
ICD-10 Finland
Malaise and fatigue
1.8
13.7
271
1676
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
13.6
507
3778
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
13.5
225
1312
N03AX16
ATC
pregabalin; oral
1.8
13.5
297
1900
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.7
13.4
361
2456
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.2
13.3
139
668
H34.1
ICD-10 Finland
Central retinal artery occlusion
10.6
13.3
25
24
TAB00
NOMESCO Finland
Lumbar puncture
3.6
13.2
59
169
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.6
13.1
99
405
H26.3
ICD-10 Finland
Drug-induced cataract
16.9
13.0
20
12
A02BC01
ATC
omeprazole; systemic
1.7
13.0
355
2422
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.6
13.0
95
382
J01CA04
ATC
amoxicillin; systemic
1.7
12.8
825
7037
J01FA10
ATC
azithromycin; systemic
1.6
12.8
547
4195
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.1
12.8
163
855
H53.2
ICD-10 Finland
Diplopia
3.7
12.8
56
158
R03AC02
ATC
salbutamol; inhalant
1.6
12.8
551
4233
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.7
12.7
90
354
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
12.7
467
3443
H25.1
ICD-10 Finland
Senile nuclear cataract
1.6
12.6
401
2845
R51.81
ICD-10 Finland
Facial pain NOS
4.6
12.5
43
97
J01AA02
ATC
doxycycline; systemic
1.7
12.4
852
7352
A02BC05
ATC
esomeprazole; systemic
1.6
12.4
472
3506
XCK00
NOMESCO Finland
Perimetry
2.4
12.3
111
498
UJF30
NOMESCO Finland
Ileoscopy through colon
2.2
12.3
124
590
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.4
12.3
105
458
UJF32
NOMESCO Finland
Coloscopy
1.7
12.1
330
2239
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.4
12.1
59
182
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
12.0
114
523
J01FF01
ATC
clindamycin; systemic
1.7
11.9
303
2011
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
11.9
391
2789
L28
ICPC
Limited function/disability (L)
1.8
11.8
227
1386
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
11.8
250
1574
M03BX02
ATC
tizanidine; oral
1.6
11.6
608
4852
L04AC07
ATC
tocilizumab; parenteral
23.2
11.6
16
7
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
11.4
217
1320
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.4
11.3
100
447
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.8
11.2
206
1238
M54.5
ICD-10 Finland
Low back pain
1.6
11.1
344
2404
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
11.0
100
450
M79.7
ICD-10 Finland
Fibromyalgia
3.9
11.0
44
116
J01FA06
ATC
roxithromycin; oral
1.6
10.9
449
3367
J01MA12
ATC
levofloxacin; systemic
1.8
10.9
225
1401
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
10.8
118
580
H15.1
ICD-10 Finland
Episcleritis
7.3
10.8
25
35
5BA08
NOMESCO Finland
NA
9.7
10.8
21
22
A04
ICPC
Weakness/tiredness general
1.9
10.8
167
946
J01MA02
ATC
ciprofloxacin; systemic
1.6
10.7
442
3312
M54.4
ICD-10 Finland
Lumbago with sciatica
1.9
10.7
178
1032
M31.1
ICD-10 Finland
Thrombotic microangiopathy
60.6
10.6
12
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
10.6
123
619
L17
ICPC
Foot/toe symptom/complaint
1.6
10.6
303
2067
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
7.1
10.6
25
36
C07AB07
ATC
bisoprolol; oral
1.5
10.6
609
4926
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.9
10.5
161
904
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
10.5
479
3674
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
3.5
10.5
48
142
M30.0
ICD-10 Finland
Polyarteritis nodosa
111.0
10.4
11
*
R02
ICPC
Shortness of breath/dyspnoea
1.9
10.4
157
879
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
4.8
10.3
33
70
C03CA01
ATC
furosemide; systemic
1.6
10.3
410
3041
SPAT1153
SPAT
Removal of sutures
1.6
10.2
391
2875
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
10.2
244
1584
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.6
10.1
75
305
A03
ICPC
Fever
2.0
10.1
143
779
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
9.2
10.0
20
22
E0000UV
ATC
NA
1.5
10.0
414
3097
H53.9
ICD-10 Finland
Visual disturbance, unspecified
3.1
9.9
54
182
A02BC03
ATC
lansoprazole; oral
1.6
9.9
358
2591
J01MA14
ATC
moxifloxacin; systemic
2.1
9.8
111
552
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.3
9.8
95
442
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
9.7
209
1312
H53.4
ICD-10 Finland
Visual field defects
3.8
9.7
39
104
L95
ICPC
Osteoporosis
2.9
9.6
57
204
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.0
9.5
131
710
4AC0X
NOMESCO Finland
NA
+∞
9.4
9
*
M31.4
ICD-10 Finland
Aortic arch syndrome [Takayasu]
+∞
9.4
9
*
NXL00
NOMESCO Finland
Biopsy of muscle
21.9
9.4
13
6
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
9.3
337
2430
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.6
9.3
69
280
R52.9
ICD-10 Finland
Pain, unspecified
2.1
9.3
105
524
R05
ICD-10 Finland
Cough
1.7
9.2
219
1416
L04AA06
ATC
mycophenolic acid; systemic
5.0
9.2
28
57
H46
ICD-10 Finland
Optic neuritis
11.6
9.1
16
14
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
9.0
259
1760
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.2
9.0
87
406
A07EC01
ATC
sulfasalazine; oral, rectal
2.1
8.9
96
469
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
8.9
100
497
SPAT1263
SPAT
Sampling
1.5
8.8
470
3684
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.1
8.7
99
495
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
8.7
183
1141
M31.0
ICD-10 Finland
Hypersensitivity angiitis
50.4
8.7
10
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
8.6
161
968
G50.1
ICD-10 Finland
Atypical facial pain
4.0
8.6
33
85
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
8.5
106
549
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
8.4
141
818
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.8
8.4
164
999
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
8.3
8
*
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
+∞
8.3
8
*
N05CF01
ATC
zopiclone; oral
1.5
8.3
387
2935
JN4BD
NOMESCO Finland
Extensive body CT
1.8
8.3
140
814
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
9.5
8.3
16
17
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.0
8.3
45
153
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.9
8.2
127
715
M53.0
ICD-10 Finland
Cervicocranial syndrome
2.1
8.2
89
437
H02AB04
ATC
methylprednisolone; systemic
1.7
8.2
169
1046
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
8.0
164
1010
A46
ICD-10 Finland
Erysipelas
1.7
7.9
174
1094
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
7.9
644
5446
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.0
7.8
99
519
H47.1
ICD-10 Finland
Papilloedema, unspecified
10.9
7.8
14
13
M01AE02
ATC
naproxen; oral, rectal
1.4
7.8
545
4472
R42
ICD-10 Finland
Dizziness and giddiness
1.5
7.7
269
1910
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.3
7.7
68
304
L01AA01
ATC
cyclophosphamide; systemic
8.1
7.6
16
20
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
7.6
260
1837
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
7.6
433
3411
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.8
7.5
46
169
NF1AA
NOMESCO Finland
Hip X-ray examination
1.8
7.5
123
707
B02.9
ICD-10 Finland
Zoster without complication
2.2
7.5
77
369
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.8
7.5
140
840
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
7.5
141
848
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.9
7.5
44
158
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
7.4
209
1409
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
7.4
139
835
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
7.4
247
1736
H26.4
ICD-10 Finland
After-cataract
1.7
7.3
145
885
4AC0L
NOMESCO Finland
NA
+∞
7.3
7
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.2
7.3
73
347
R03BB04
ATC
tiotropium bromide; inhalant
1.8
7.2
126
741
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.2
7.2
36
116
B01AC04
ATC
clopidogrel; oral
1.6
7.2
204
1375
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.2
7.2
68
316
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
7.2
354
2703
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
2.0
7.1
88
458
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
7.1
107
597
M01AH03
ATC
valdecoxib; oral
2.1
7.1
79
393
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.2
7.1
35
112
R63.4
ICD-10 Finland
Abnormal weight loss
2.5
7.1
51
207
PA7BD
NOMESCO Finland
CT angiography of neck and brain
3.5
7.0
31
91
R20.2
ICD-10 Finland
Paraesthesia of skin
2.2
7.0
71
337
CS494
NOMESCO Finland
Other visual field testing
2.9
7.0
40
139
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
4.0
7.0
26
66
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.4
7.0
55
232
R03DC03
ATC
montelukast; oral
1.7
7.0
154
971
C08CA01
ATC
amlodipine; oral
1.4
6.9
447
3582
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
6.9
507
4160
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
7.6
6.9
15
20
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.9
6.9
103
573
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.5
6.9
49
198
G47.3
ICD-10 Finland
Sleep apnoea
1.6
6.9
196
1323
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
4.8
6.9
21
44
L03
ICPC
Low back symptom/complaint
1.5
6.8
253
1817
R01AD01
ATC
beclometasone; nasal
1.7
6.8
151
954
L01
ICPC
Neck symptom/complaint
1.7
6.8
146
915
PAA99
NOMESCO Finland
Exploration of other arterial branch originating from aortic arch arteries
40.3
6.8
8
*
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.9
6.7
39
139
SPAT1301
SPAT
No procedures
1.4
6.7
365
2833
H02AB09
ATC
hydrocortisone; systemic
3.2
6.7
33
106
G50.0
ICD-10 Finland
Trigeminal neuralgia
3.8
6.7
26
69
R52.2
ICD-10 Finland
Other chronic pain
2.7
6.7
44
170
A02BA02
ATC
ranitidine; systemic
1.5
6.7
242
1729
M05BA06
ATC
ibandronic acid; systemic
2.9
6.7
38
132
SPAT1310
SPAT
Counselling related to known health issue
1.4
6.6
337
2580
J05AB11
ATC
valaciclovir; oral
1.7
6.6
132
806
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.4
6.6
53
228
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.4
6.6
405
3211
C08CA05
ATC
nifedipine; systemic
2.0
6.5
81
421
R55
ICD-10 Finland
Syncope and collapse
1.7
6.5
133
820
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.8
6.5
111
647
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
5.7
6.5
17
30
F29
ICPC
Eye symptom/complaint other
1.9
6.5
94
519
Z71.8
ICD-10 Finland
Other specified counselling
1.5
6.4
223
1575
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
6.4
101
572
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.3
6.4
30
93
R74
ICPC
Upper respiratory infection acute
1.5
6.4
205
1422
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
6.4
72
363
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.7
6.4
123
744
L20
ICPC
Joint symptom/complaint NOS
2.7
6.4
41
155
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
6.4
409
3265
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
6.4
181
1222
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.9
6.3
91
501
M05.2
ICD-10 Finland
Rheumatoid vasculitis
18.1
6.3
9
5
L08
ICPC
Shoulder symptom/complaint
1.5
6.3
205
1429
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
6.2
175
1177
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
6.2
308
2342
ZXA00
NOMESCO Finland
Right side
1.4
6.2
319
2444
Z00.0
ICD-10 Finland
General medical examination
1.5
6.2
200
1391
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
6.2
712
6263
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.2
422
3400
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.5
6.1
45
186
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.5
6.1
43
173
J37.0
ICD-10 Finland
Chronic laryngitis
2.6
6.0
40
156
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
6.0
486
4026
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.4
6.0
46
193
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
256
346
9.04
185.53
2.2
1.4
295.0
152.3
titre
0.41
16
13
209
276
8.89
153.30
1.7
1.6
0.1
0.1
iu/ml
0.29
43
56
883
4840
3.79
104.45
12.7
5.6
2.1
2.8
%
26.53
855
4451
890
4941
3.77
102.32
12.8
5.8
24.3
26.4
%
7.48
860
4531
875
4858
3.66
99.38
12.4
5.5
62.1
58.4
%
15.30
843
4481
994
6071
4.08
95.54
14.8
8.7
5.0
4.2
e9/l
22.04
915
5258
162
278
6.54
92.47
1.8
1.5
0.2
0.2
g/l
0.97
150
262
163
288
6.36
90.32
1.8
1.5
1.3
1.2
g/l
3.37
153
272
967
5916
3.78
89.95
7.9
6.5
1.2
1.2
mmol/l
1.05
855
4978
816
4547
3.28
87.65
3.0
2.3
82.3
80.0
nmol/l
1.41
759
3946
419
1594
3.45
86.17
1.4
1.2
33.2
39.6
iu/ml
0.45
131
509
406
1542
3.42
83.34
1.4
1.2
7.7
13.6
u/ml
1.09
132
533
323
1072
3.71
81.63
1.7
2.9
65.1
66.2
g/l
1.70
292
963
165
332
5.57
79.46
1.4
1.2
0.2
1.4
u/ml
0.78
14
22
682
3572
3.00
79.00
2.8
2.1
113.6
231.5
u/l
4.93
646
3333
153
299
5.69
75.96
2.3
1.7
—
—
—
0
0
882
5406
3.13
75.15
6.6
5.7
1.2
1.2
mmol/l
0.29
849
4840
288
954
3.62
72.23
2.2
2.0
339.0
381.8
nmol/l
3.11
260
856
1099
7886
4.20
68.00
15.7
4.2
17.1
14.5
mm/h
5.51
1063
7162
220
741
3.39
52.60
2.5
2.9
10.2
10.9
g/l
0.84
199
669
146
373
4.30
52.14
1.5
2.7
0.0
0.0
g/l
0.95
129
341
172
500
3.83
51.39
1.5
2.7
3.9
3.7
g/l
0.60
129
354
172
501
3.82
51.23
1.5
2.7
—
—
—
0
0
172
501
3.82
51.23
1.5
2.7
8.8
7.5
g/l
8.68
132
369
163
466
3.87
49.82
1.5
2.7
3.9
3.2
g/l
8.00
130
361
161
469
3.79
47.84
1.5
2.7
9.4
10.3
g/l
1.82
138
392
149
420
3.89
46.37
1.5
1.9
33.4
38.3
u/l
2.45
133
364
1086
8381
3.22
46.07
13.1
7.5
72.5
80.0
u/l
7.89
1060
7795
150
433
3.80
45.07
1.7
2.8
0.3
1.4
g/l
3.40
131
370
131
348
4.09
44.22
1.5
2.7
0.0
0.0
g/l
0.00
115
321
131
352
4.04
43.51
1.5
2.7
0.0
0.0
g/l
0.00
115
322
139
398
3.80
42.19
1.5
2.5
32.9
37.4
g/l
11.03
117
336
766
5282
2.16
37.22
6.2
4.3
0.0
0.0
estimate
0.50
183
940
893
6549
2.27
37.00
5.7
4.7
6.7
6.8
mmol/l
0.97
859
6159
756
5197
2.15
36.90
6.2
4.2
0.0
0.0
estimate
0.00
180
958
53
73
7.54
36.66
1.4
1.1
185.0
75.4
titre
0.51
12
13
642
4163
2.11
36.38
4.3
3.3
—
—
—
0
0
512
3052
2.15
36.16
2.7
2.2
3.2
3.2
mg/l
0.02
442
2542
103
271
4.05
35.08
1.5
2.0
10.2
12.3
mg/l
2.07
94
248
750
5221
2.09
34.36
8.0
5.7
0.0
0.0
estimate
0.00
185
944
83
197
4.44
32.35
1.4
1.2
3.1
7.8
u/ml
—
7
13
146
509
3.11
32.29
1.7
1.9
1.1
2.1
ug/l
0.72
122
438
130
426
3.29
31.87
1.6
3.7
2.0
1.8
ratio
0.10
12
32
371
2041
2.16
31.37
2.2
1.9
—
—
—
0
0
131
437
3.23
31.18
1.7
3.7
40.3
65.0
mg/l
1.02
102
365
131
438
3.22
31.06
1.7
3.7
30.1
87.0
mg/l
1.21
103
368
952
7389
2.20
30.96
6.8
5.2
188.0
2342.2
e6/l
—
6
136
278
1379
2.31
30.17
2.9
3.8
239.8
250.1
u/l
0.42
258
1290
90
245
3.88
29.18
1.5
1.2
8.2
3.8
u/ml
0.80
17
27
91
250
3.85
29.13
1.6
1.2
15.7
7.5
u/ml
0.53
18
41
627
4261
1.94
28.78
3.4
2.8
176.8
138.9
ug/l
1.71
571
3821
39
53
7.56
27.25
1.2
1.1
5.3
6.2
u/l
0.43
26
44
334
1856
2.09
26.91
2.6
2.4
11.3
12.3
umol/l
1.52
307
1699
504
3241
1.93
26.75
3.8
3.3
0.3
0.5
e6/l
2.53
412
2476
72
178
4.23
26.60
2.5
5.7
367.3
417.8
iu/ml
—
8
27
786
5877
1.91
25.80
5.6
6.1
10.4
11.7
umol/l
2.03
752
5547
308
1698
2.08
25.13
2.6
2.4
2.3
2.3
g/l
0.67
282
1557
707
5148
1.86
24.80
5.0
4.6
33.5
34.8
g/l
7.14
660
4752
60
140
4.45
23.87
1.6
1.6
52.2
66.2
%
1.59
39
95
77
219
3.68
23.42
1.2
1.2
3.8
3.8
mmol/l
0.37
69
208
289
1607
2.04
22.77
2.7
2.5
20.1
21.8
%
1.11
247
1353
436
2795
1.86
22.45
2.9
2.8
4081.9
8214.8
umol/l
1.22
377
2357
81
247
3.44
22.17
1.2
1.3
469.3
516.2
mg/l
0.49
76
234
513
3470
1.81
22.08
2.7
2.4
58.7
57.2
u/l
0.18
474
3161
1151
10132
2.67
21.07
35.7
16.6
23.6
25.9
mg/l
1.92
1088
8236
57
141
4.19
21.04
1.5
2.9
165.0
2263.5
u/ml
—
5
12
394
2494
1.85
20.82
3.1
2.6
5.0
5.6
e6/l
0.46
351
2197
264
1466
2.01
20.68
2.3
2.5
1.9
1.8
%
0.31
239
1284
259
1440
2.01
20.17
2.1
1.8
—
—
—
0
0
94
332
2.98
20.17
1.5
1.4
—
—
—
0
0
623
4567
1.72
19.50
5.7
4.1
29.7
49.9
ng/l
1.94
496
3490
179
877
2.21
19.41
1.7
1.6
—
—
—
0
0
256
1440
1.98
19.20
2.1
1.8
—
—
—
0
0
41
84
5.01
19.07
1.1
1.1
—
—
—
0
0
671
5055
1.70
18.71
2.3
2.1
90.9
94.3
pmol/l
1.13
367
2504
64
189
3.51
18.41
4.3
3.0
63.5
59.7
%
1.35
64
189
556
3998
1.70
18.31
3.4
3.1
1542.7
1615.6
ng/l
0.14
497
3439
31
51
6.21
18.17
1.1
1.1
—
—
—
0
0
107
429
2.63
18.07
1.9
2.2
283.9
501.9
ug/l
0.77
95
402
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
55
5.94
17.96
1.1
1.2
—
—
—
0
0
42
93
4.64
17.84
1.1
1.1
—
—
—
0
0
62
185
3.47
17.56
2.6
3.9
0.7
1.5
%
1.37
54
148
291
1763
1.85
17.23
2.0
1.9
29.3
29.6
s
0.29
283
1700
60
180
3.45
16.86
4.1
2.8
5.2
4.5
e9/l
1.34
60
180
194
1034
2.04
16.78
2.2
1.9
255.5
144.9
ug/g
1.34
159
802
61
189
3.34
16.30
1.5
1.2
64.8
42.0
u/ml
—
6
21
54
155
3.60
16.22
1.3
1.1
—
—
—
0
0
349
2267
1.75
16.21
1.9
1.6
1.4
1.3
mg/l
0.16
279
1774
418
2855
1.70
16.17
7.2
4.6
0.0
0.0
estimate
0.50
182
918
128
590
2.30
15.97
1.5
1.8
2.1
1.6
g/l
5.28
109
514
385
2582
1.71
15.89
2.0
1.8
1140.1
1191.3
nmol/l
0.49
287
1887
21
26
8.20
15.79
1.1
1.1
—
—
—
0
0
556
4118
1.63
15.52
3.2
3.5
2.3
2.4
mmol/l
1.77
465
3513
78
294
2.76
14.86
1.7
1.7
10348.1
15917.2
e6/l
0.85
62
216
32
67
4.88
14.54
1.1
1.1
—
—
—
0
0
32
67
4.88
14.54
1.1
1.1
—
—
—
0
0
32
68
4.80
14.29
1.1
1.1
—
—
—
0
0
32
68
4.80
14.29
1.1
1.1
—
—
—
0
0
32
68
4.80
14.29
1.1
1.1
—
—
—
0
0
40
103
3.98
14.03
1.1
1.3
—
—
—
0
0
33
74
4.55
13.83
1.1
1.1
—
—
—
0
0
36
87
4.23
13.74
1.2
1.0
—
—
—
0
0
26
48
5.51
13.57
1.1
1.2
—
—
—
0
0
310
2034
1.70
13.54
3.2
2.8
2.0
1.2
e6/l
0.33
201
1174
56
185
3.12
13.51
1.2
1.3
—
—
—
0
0
61
212
2.97
13.49
1.2
1.2
—
—
—
0
0
26
50
5.29
12.99
1.1
1.0
—
—
—
0
0
196
1143
1.85
12.80
3.2
2.5
5.0
6.4
ug/l
1.04
161
987
624
4893
1.55
12.78
2.8
2.4
—
—
—
0
0
61
221
2.85
12.53
1.2
1.2
26.2
44.8
e6/l
0.25
44
177
61
221
2.85
12.53
1.2
1.3
2141.2
768.2
e6/l
0.30
48
184
176
1003
1.88
12.34
4.4
3.6
1.2
1.2
mmol/l
1.51
164
862
41
118
3.56
12.31
2.7
3.3
59.0
55.7
%
0.35
30
82
67
258
2.69
12.27
1.3
1.4
—
—
—
0
0
67
258
2.69
12.27
1.3
1.4
—
—
—
0
0
39
109
3.66
12.22
1.2
1.2
46.3
52.9
u/l
0.63
25
80
919
7902
1.61
12.21
4.6
4.1
15.3
15.1
pmol/l
2.05
835
7021
283
1857
1.68
12.21
2.6
3.1
0.8
0.8
mmol/l
0.04
257
1716
520
3950
1.54
12.10
6.9
4.6
—
—
—
0
0
286
1888
1.67
12.04
3.5
3.0
4.6
2.6
e6/l
1.42
176
1037
334
2302
1.61
11.81
5.9
4.0
109.0
323.2
ng/l
3.74
284
1967
350
2458
1.59
11.38
2.8
3.0
2.5
2.5
mmol/l
0.45
300
2157
44
141
3.20
11.19
1.2
1.2
—
—
—
0
0
94
456
2.15
10.34
2.1
1.8
—
—
—
0
0
238
1557
1.65
10.22
5.8
5.0
1.1
1.0
mmol/l
0.83
220
1413
173
1039
1.77
10.15
6.2
6.2
1.4
1.4
mmol/l
0.13
163
1005
19
35
5.50
9.94
1.1
1.0
—
—
—
0
0
51
191
2.74
9.89
1.5
1.4
—
—
—
0
0
182
1120
1.73
9.80
1.4
1.3
—
—
—
0
0
40
132
3.10
9.72
1.2
1.2
290.0
312.8
u/ml
0.15
20
70
166
1015
1.73
9.12
3.4
3.5
93.1
91.0
ng/l
0.09
149
850
166
1015
1.73
9.12
2.4
2.3
29.3
36.4
u/l
1.74
139
848
404
3045
1.48
9.12
1.7
1.6
19.2
20.8
nmol/l
1.48
350
2519
1062
9685
1.63
8.82
7.5
6.5
41.2
40.8
mmol/mol
0.80
987
8781
247
1686
1.58
8.81
37.9
29.4
1.3
1.4
inr
0.35
24
208
1041
9452
1.60
8.75
5.9
5.1
1.8
2.2
mu/l
1.76
957
8442
84
419
2.08
8.62
2.8
2.8
—
—
—
0
0
124
710
1.83
8.51
1.6
1.5
—
—
—
0
0
19
41
4.69
8.36
1.1
1.1
—
74.3
%
—
0
7
35
117
3.05
8.35
1.4
1.6
—
—
—
0
0
39
139
2.86
8.33
3.8
3.6
—
—
—
0
0
94
496
1.97
8.27
2.4
1.9
—
—
—
0
0
32
102
3.19
8.27
1.4
1.5
31.0
28.5
%
0.13
19
65
49
198
2.53
8.22
1.5
1.4
—
—
—
0
0
165
1039
1.68
8.12
6.9
6.4
10.6
10.5
mmol/l
0.01
158
978
1149
10748
1.83
8.11
30.3
19.9
139.3
139.6
mmol/l
2.52
1132
10453
21
51
4.17
8.01
1.2
1.4
7.7
1.9
%
—
6
10
49
201
2.50
7.98
1.1
1.1
—
—
—
0
0
135
813
1.74
7.81
1.9
1.6
—
—
—
0
0
912
8124
1.45
7.71
35.5
20.6
14.3
13.9
%
12.24
896
7931
26
76
3.47
7.69
1.1
1.1
—
—
—
0
0
16
32
5.05
7.67
1.1
1.1
1.0
1.1
ratio
—
5
9
32
107
3.04
7.65
1.0
1.0
—
—
—
0
0
1148
10765
1.79
7.62
30.7
20.1
4.0
4.0
mmol/l
2.29
1127
10456
95
518
1.90
7.60
1.3
1.2
159.6
215.2
u/ml
0.41
87
466
44
176
2.55
7.56
1.6
1.4
—
—
—
0
0
176
1147
1.62
7.56
4.0
3.4
1.8
2.0
mmol/l
0.26
151
918
66
316
2.15
7.55
1.2
1.2
—
—
—
0
0
66
318
2.14
7.44
1.2
1.2
—
—
—
0
0
13
22
5.96
7.39
1.2
1.2
—
—
—
0
0
704
6025
1.38
7.27
3.8
3.2
52.3
52.8
u/l
0.06
659
5451
40
156
2.62
7.24
1.6
1.4
—
—
—
0
0
1141
10709
1.73
7.16
21.4
11.3
23.3
24.1
u/l
1.28
1120
10246
13
23
5.70
7.07
1.5
1.4
0.2
0.4
ug/l
—
8
13
58
271
2.20
7.07
1.8
1.6
—
—
—
0
0
174
1155
1.59
6.91
4.0
3.4
5.8
5.8
kpa
0.45
168
1120
65
321
2.08
6.89
1.7
1.6
—
—
—
0
0
31
109
2.89
6.82
1.5
1.7
—
—
—
0
0
10
6
16.79
6.75
1.1
1.0
—
—
—
0
0
66
331
2.05
6.72
1.5
1.6
—
—
—
0
0
10
14
7.19
6.70
1.2
1.3
—
—
—
0
0
39
157
2.53
6.64
1.5
1.5
—
—
—
0
0
399
3146
1.39
6.62
2.9
3.2
31.1
34.0
u/l
0.94
378
2987
273
2017
1.45
6.51
1.4
1.2
1.2
1.4
u/ml
0.30
65
510
13
25
5.24
6.49
1.9
1.5
—
—
—
0
0
18
46
3.96
6.45
1.3
1.1
1.0
1.1
u/l
1.09
11
24
1039
9606
1.48
6.24
25.3
15.9
72.6
73.2
ml/min/173m2
0.37
955
7937
176
1201
1.54
6.18
2.2
2.7
6.7
8.8
umol/l
0.81
156
1047
54
261
2.12
6.08
1.9
1.6
—
—
—
0
0
21
63
3.37
6.01
1.6
1.7
3.4
7.6
u/l
0.65
11
35
30
112
2.72
5.95
1.5
1.3
18664.5
175910.6
e6/l
1.03
18
76
51
244
2.14
5.90
1.5
1.4
—
—
—
0
0
33
130
2.58
5.90
1.1
1.3
110.1
111.9
u/ml
—
8
18
19
54
3.56
5.89
1.9
1.9
—
—
—
0
0
1159
11009
1.70
5.84
45.3
24.7
263.3
245.8
e9/l
13.74
1142
10677
596
5076
1.33
5.82
4.3
4.1
—
—
—
0
0
1159
11011
1.70
5.81
45.3
24.7
4.3
4.4
e12/l
5.58
1140
10637
29
108
2.73
5.78
1.2
1.1
5.0
2.6
u/ml
—
7
33
1159
11014
1.70
5.77
45.6
24.9
128.9
131.9
g/l
11.30
1146
10800
1159
11014
1.70
5.77
45.3
24.8
7.8
6.8
e9/l
40.80
1141
10636
1026
9500
1.44
5.76
4.5
4.2
1.3
1.3
mmol/l
0.04
922
8379
13
28
4.68
5.74
1.2
1.2
—
—
—
0
0
75
417
1.85
5.70
1.3
1.3
—
—
—
0
0
62
327
1.94
5.53
1.3
1.5
299.9
277.4
ug/g
0.34
30
196
35
148
2.40
5.42
1.3
1.5
—
—
—
0
0
34
142
2.43
5.41
1.5
1.5
—
—
—
0
0
93
561
1.71
5.39
3.0
3.1
4.3
4.4
pmol/l
0.06
76
479
34
143
2.42
5.34
1.5
1.5
—
—
—
0
0
34
144
2.40
5.26
1.5
1.5
—
—
—
0
0
164
1141
1.50
5.25
3.4
3.0
218.2
236.9
ng/l
0.23
149
1049
79
460
1.77
5.19
4.7
4.2
25.0
25.1
mmol/l
0.15
72
422
70
393
1.83
5.18
1.3
1.3
—
—
—
0
0
13
31
4.23
5.10
1.2
1.1
—
—
—
0
0
13
31
4.23
5.10
1.2
1.1
—
—
—
0
0
14
36
3.92
4.99
1.2
1.1
—
—
—
0
0
1071
10061
1.44
4.96
5.9
5.1
5.9
6.1
mmol/l
3.09
976
8929
156
1087
1.50
4.96
2.0
2.0
0.2
0.2
g/l
1.87
138
1011
33
142
2.36
4.95
1.5
1.5
—
—
—
0
0
33
142
2.36
4.95
1.5
1.5
—
—
—
0
0
1058
9925
1.42
4.86
5.1
4.8
4.5
4.5
mmol/l
0.01
964
8931
1049
9826
1.42
4.86
5.1
4.7
1.6
1.5
mmol/l
3.89
948
8770
12
28
4.32
4.83
2.5
1.7
—
—
—
0
0
33
144
2.33
4.80
1.5
1.5
—
—
—
0
0
11
24
4.62
4.78
1.4
1.4
—
—
—
0
0
193
1413
1.43
4.76
6.9
6.5
5.0
5.1
kpa
1.29
183
1341
193
1414
1.43
4.74
6.9
6.5
12.2
11.9
kpa
0.22
182
1344
27
108
2.53
4.73
1.2
1.1
4.9
5.4
u/ml
—
9
53
338
2723
1.33
4.62
2.6
2.4
—
—
—
0
0
26
105
2.51
4.48
1.7
1.5
—
—
—
0
0
26
105
2.51
4.48
1.7
1.5
—
—
—
0
0
26
105
2.51
4.48
1.7
1.5
—
—
—
0
0
21
76
2.79
4.46
1.1
1.0
—
—
—
0
0
89
560
1.63
4.43
3.8
3.6
24.4
24.2
mmol/l
0.38
79
511
114
764
1.54
4.36
8.5
8.0
0.6
0.7
%
0.21
114
756
139
972
1.48
4.35
3.4
2.7
4.7
4.4
kpa
0.73
133
939
45
233
1.97
4.30
1.7
1.7
5.4
5.3
iu/l
0.01
11
73
50
269
1.89
4.27
1.7
1.6
—
—
—
0
0
40
199
2.04
4.26
1.9
1.6
—
—
—
0
0
105
696
1.56
4.22
4.4
3.7
1.5
2.1
mmol/l
0.71
80
529
110
737
1.54
4.22
4.5
3.7
5.1
5.2
kpa
0.69
97
681
99
648
1.57
4.20
7.7
7.1
24.8
25.0
mmol/l
0.30
99
643
14
41
3.44
4.19
1.1
1.2
—
—
—
0
0
26
109
2.41
4.16
3.1
2.2
—
—
—
0
0
17
57
3.01
4.13
2.1
1.7
14.8
16.5
%
—
5
23
189
1415
1.40
4.10
6.9
6.5
1.0
1.3
mmol/l
0.51
154
1099
10
23
4.37
4.09
1.2
1.1
—
—
—
0
0
21
80
2.65
4.07
1.4
1.3
—
—
—
0
0
8
10
8.04
4.06
1.1
1.2
—
—
—
0
0
14
42
3.36
4.05
1.2
1.2
—
—
—
0
0
17
58
2.96
4.02
1.1
1.3
—
—
—
0
0
17
58
2.96
4.02
1.1
1.3
—
—
—
0
0
9
14
6.47
3.98
1.2
1.3
—
—
—
0
0
1075
10192
1.39
3.93
5.8
5.4
2.6
2.6
mmol/l
1.18
976
9129
47
257
1.86
3.85
5.9
4.9
5.0
5.1
kpa
0.63
47
252
123
861
1.48
3.84
3.3
2.7
54.5
60.8
ml/min/173m2
1.12
53
374
11
29
3.82
3.81
1.1
1.1
1499.7
1761.6
miu/ml
0.39
11
29
12
34
3.55
3.77
1.0
1.2
—
—
—
0
0
16
55
2.93
3.74
2.5
1.9
0.2
0.2
e9/l
0.77
16
49
112
774
1.49
3.73
8.7
7.8
1.4
1.3
%
0.35
112
765
94
628
1.54
3.68
8.3
8.6
24.5
24.5
mmol/l
0.02
86
579
8
12
6.70
3.67
1.0
2.6
—
—
—
0
0
156
1153
1.40
3.65
7.9
7.2
118.9
119.2
g/l
0.07
151
1105
20
80
2.52
3.55
1.5
1.3
—
—
—
0
0
11
31
3.57
3.48
1.2
1.1
—
—
—
0
0
11
31
3.57
3.48
1.7
1.3
42.8
19.3
%
—
5
21
59
358
1.68
3.43
3.5
3.3
0.9
0.8
nmol/l
0.23
47
280
31
154
2.04
3.37
1.7
1.6
—
—
—
0
0
7
10
7.03
3.36
1.9
1.0
—
—
—
0
0
11
33
3.35
3.19
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
66
422
1.60
3.15
2.9
2.5
0.4
0.4
u/ml
0.37
40
240
932
8742
1.26
3.13
31.1
18.6
37.6
38.3
%
0.99
555
5435
8
16
5.02
3.05
1.3
1.1
—
—
—
0
0
8
16
5.02
3.05
1.5
1.1
—
—
—
0
0
16
62
2.60
3.05
2.1
2.0
804.9
726.1
e6/l
0.12
11
28
24
113
2.15
3.01
1.2
1.7
—
—
—
0
0
412
3562
1.23
2.99
3.1
3.1
6.8
6.8
mmol/l
0.09
335
2912
17
69
2.48
2.96
1.1
1.3
—
—
—
0
0
283
2349
1.26
2.95
7.5
4.7
1.0
1.0
kg/l
0.98
29
354
313
2632
1.25
2.92
1.8
1.8
26877969.1
16351145.6
pmol/l
0.15
253
2110
17
71
2.41
2.80
1.3
1.1
—
—
—
0
0
15
59
2.56
2.79
1.4
1.3
—
—
—
0
0
15
59
2.56
2.79
1.4
1.3
—
—
—
0
0
20
91
2.22
2.74
2.1
1.6
—
—
—
0
0
162
1273
1.31
2.59
4.6
3.5
—
—
—
0
0
20
94
2.15
2.55
1.5
1.6
—
—
—
0
0
167
1321
1.30
2.54
2.8
4.0
8.4
21.0
ug/l
0.97
139
1101
10
33
3.05
2.53
1.2
1.2
—
—
—
0
0
42
256
1.66
2.48
1.6
1.6
—
—
—
0
0
19
91
2.10
2.33
1.2
1.7
—
—
—
0
0
23
119
1.95
2.31
1.2
1.4
590.3
273.0
pmol/l
0.78
17
92
180
1461
1.27
2.26
5.0
4.8
33.6
33.6
%
0.00
139
936
185
1509
1.27
2.23
12.3
8.0
—
—
—
0
0
9
29
3.12
2.22
1.0
1.4
—
—
—
0
0
9
29
3.12
2.22
1.2
1.1
—
—
—
0
0
14
60
2.35
2.22
2.1
1.5
—
—
—
0
0
23
121
1.92
2.21
2.0
1.7
—
—
—
0
0
14
61
2.31
2.15
2.1
1.5
—
—
—
0
0
9
30
3.01
2.15
1.1
1.1
—
—
—
0
0
74
532
1.42
2.11
1.1
1.2
198.2
132.2
iu/ml
0.48
18
189
12
49
2.46
2.10
1.2
1.2
—
—
—
0
0
14
62
2.27
2.08
2.0
1.6
—
—
—
0
0
14
62
2.27
2.08
2.0
1.6
—
—
—
0
0
14
62
2.27
2.08
1.9
1.6
—
—
—
0
0
14
62
2.27
2.08
2.0
1.6
—
—
—
0
0
13
56
2.34
2.05
6.9
4.1
—
—
—
0
0
16
76
2.12
2.03
2.1
1.4
—
—
—
0
0
12
50
2.41
2.03
1.2
1.2
—
—
—
0
0
5
11
4.56
1.94
1.0
1.3
—
—
—
0
0
41
267
1.55
1.91
1.8
1.4
—
—
—
0
0
8
28
2.87
1.86
1.0
1.1
—
—
—
0
0
19
100
1.91
1.86
1.1
1.1
—
—
—
0
0
63
453
1.41
1.83
4.8
3.4
1.3
1.4
mmol/l
0.54
63
443
11
47
2.35
1.78
1.0
1.1
—
—
—
0
0
18
95
1.91
1.76
1.4
1.3
—
—
—
0
0
32
201
1.61
1.75
2.6
1.9
1.7
1.6
mmol/l
0.30
32
195
414
3731
1.16
1.75
3.9
3.9
14.3
8.7
mg/mmol
0.96
261
2280
5
13
3.86
1.71
13.2
13.1
4.6
6.0
mmol/l
—
5
13
5
14
3.58
1.61
1.6
1.4
34.8
49.2
umol/l
—
5
14
5
14
3.58
1.61
1.8
1.1
92.3
86.8
ng/l
—
5
8
13
64
2.04
1.54
1.4
2.2
—
—
—
0
0
5
15
3.34
1.52
1.4
1.2
—
—
—
0
0
5
15
3.34
1.52
1.2
1.8
—
—
—
0
0
5
16
3.13
1.44
1.2
1.0
—
—
—
0
0
9
41
2.20
1.37
1.0
1.4
—
—
—
0
0
5
17
2.95
1.36
1.0
1.0
—
—
—
0
0
347
3144
1.14
1.33
5.4
5.5
5.3
3.1
ug/l
0.37
299
2770
36
250
1.45
1.32
3.0
2.5
15.3
15.9
%
0.37
14
118
6
25
2.41
1.24
1.2
1.4
—
—
—
0
0
10
49
2.05
1.22
2.3
1.7
—
—
—
0
0
10
49
2.05
1.22
2.3
1.7
—
—
—
0
0
55
419
1.33
1.20
1.0
1.1
—
—
—
0
0
25
165
1.53
1.18
2.7
2.5
15.1
27.2
mg/l
—
8
42
11
57
1.94
1.17
1.6
1.9
14.7
16.6
nmol/l
0.61
11
52
10
50
2.01
1.16
2.4
1.7
—
—
—
0
0
310
2824
1.13
1.09
1.7
1.6
1.3
1.3
mmol/l
0.00
255
2315
18
278
0.64
1.07
5.7
4.0
36.1
27.7
mg/l
0.51
12
179
41
310
1.33
0.97
1.6
1.5
—
—
—
0
0
92
771
1.21
0.96
1.5
1.7
1.7
1.6
%
0.55
79
638
6
27
2.23
0.93
1.3
1.1
—
—
—
0
0
278
2544
1.12
0.91
4.6
4.7
20.2
21.5
%
0.77
137
1309
32
237
1.36
0.88
1.3
2.6
25.0
34.7
umol/l
3.21
27
190
6
31
1.94
0.84
1.8
1.2
16.0
15.1
pmol/l
—
6
21
10
57
1.76
0.83
1.0
1.4
0.7
1.0
g/l
—
10
57
34
258
1.33
0.82
2.4
2.8
1.9
1.7
mg/l
0.42
29
229
35
452
0.77
0.80
1.5
1.8
—
—
—
0
0
11
67
1.65
0.75
3.5
1.3
—
—
—
0
0
11
67
1.65
0.75
3.5
1.3
—
—
—
0
0
36
280
1.29
0.74
1.6
1.4
—
—
—
0
0
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
7
38
1.85
0.73
1.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
26
1.93
0.70
1.0
3.5
187.8
162.0
%
—
5
26
5
27
1.86
0.68
1.0
1.3
—
—
—
0
0
32
250
1.29
0.66
1.1
1.3
—
—
—
0
0
18
129
1.40
0.63
3.2
2.5
—
—
—
0
0
73
629
1.17
0.62
3.7
2.8
0.2
0.3
e6/l
0.84
73
614
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
18
132
1.37
0.57
1.1
1.2
12.3
10.8
u/l
0.18
13
97
62
535
1.17
0.53
2.0
2.2
12.8
12.4
nmol/l
0.12
52
456
35
286
1.23
0.53
2.0
2.4
291.5
77.6
ug/min
0.43
17
168
195
1809
1.09
0.52
3.3
3.3
0.6
0.8
ug/l
4.00
143
1268
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
2.5
—
0.9
—
0
10
0
17
0.00
0.40
0.0
1.4
—
8.3
—
0
9
17
132
1.29
0.40
1.9
1.4
—
—
—
0
0
53
470
1.13
0.35
2.6
3.2
80.4
3150.6
u/ml
0.82
42
401
19
154
1.24
0.34
1.2
1.1
—
—
—
0
0
34
295
1.16
0.31
3.6
3.0
24.1
25.5
mmol/l
0.91
27
250
16
194
0.82
0.28
1.5
1.6
—
—
—
0
0
8
65
1.23
0.27
7.8
1.8
—
—
—
0
0
14
114
1.23
0.25
1.4
2.0
193.8
213.6
pmol/l
0.44
14
107
14
114
1.23
0.25
1.0
1.0
—
—
—
0
0
9
77
1.17
0.24
2.2
2.5
—
—
—
0
0
22
189
1.17
0.24
1.4
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
23
252
0.91
0.12
1.3
1.7
5.6
4.5
mg/l
0.16
15
197
130
1270
1.03
0.08
1.3
1.3
—
—
—
0
0
7
68
1.03
0.08
1.9
4.2
—
—
—
0
0
7
81
0.86
0.07
1.1
1.2
—
—
—
0
0
20
214
0.93
0.07
3.2
3.9
30.6
32.8
u/ml
0.09
20
209
12
110
1.09
0.05
1.7
2.3
0.3
1.9
u/field
—
6
34
14
132
1.06
0.02
2.9
4.3
275.8
355.8
umol/l
—
9
113
29
282
1.03
0.02
1.1
1.2
—
—
—
0
0
25
257
0.97
0.01
2.2
2.1
126.1
126.6
g/l
0.05
17
187
5
55
0.91
0.00
1.6
1.7
—
—
—
0
0
5
53
0.94
0.00
1.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
5.2
—
376.6
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
2.8
—
0
6
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
26.8
—
0
9
20
200
1.00
0.00
1.4
1.6
0.8
0.9
nmol/l
—
10
163
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
7.7
—
0
5
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: GIANT_CELL_TEMP_ARTERITIS – Giant cell arteritis with polymyalgia rheumatica
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).